| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003782212 |
| P356 | DOI | 10.1186/1476-4598-14-2 |
| P932 | PMC publication ID | 4429406 |
| P698 | PubMed publication ID | 25971746 |
| P5875 | ResearchGate publication ID | 276297735 |
| P2093 | author name string | Hui Wang | |
| Wen-Sheng Li | |||
| Zhe Yu | |||
| Lun Luo | |||
| Zhuo-Peng Ye | |||
| Jian-Qing Pan | |||
| Xin-Jie Ning | |||
| P2860 | cites work | Structure-function analysis of Qk1: a lethal point mutation in mouse quaking prevents homodimerization | Q24522616 |
| Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia | Q24544238 | ||
| Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins | Q24633428 | ||
| A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis | Q24649156 | ||
| Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH | Q24654938 | ||
| Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation | Q28117650 | ||
| TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
| Controlling TGF-beta signaling | Q28139621 | ||
| Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R/TLR signaling | Q28273752 | ||
| The quaking I-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm | Q28585178 | ||
| Malignant gliomas in adults | Q29615708 | ||
| Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer | Q29616379 | ||
| Malignant astrocytic glioma: genetics, biology, and paths to treatment | Q29618156 | ||
| microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma | Q30407637 | ||
| Genetic events and the role of TGF beta in epithelial tumour progression | Q33643339 | ||
| Specificity, diversity, and regulation in TGF-beta superfamily signaling. | Q33792305 | ||
| TGF-beta and cancer. | Q33804136 | ||
| QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2 | Q34028448 | ||
| A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival | Q34108339 | ||
| Gliomagenesis: genetic alterations and mouse models | Q34186001 | ||
| Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway | Q34411179 | ||
| STAR, a gene family involved in signal transduction and activation of RNA. | Q34452653 | ||
| Common fragile sites, extremely large genes, neural development and cancer | Q34459085 | ||
| The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: downregulated in multiple brain regions in schizophrenia | Q34570430 | ||
| The molecular and genetic basis of neurological tumours | Q34770308 | ||
| Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27 | Q35022507 | ||
| Loss of p53 in quaking viable mice leads to Purkinje cell defects and reduced survival | Q35617133 | ||
| Development of TGF-beta signalling inhibitors for cancer therapy | Q35968389 | ||
| STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA | Q36110907 | ||
| Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. | Q36564164 | ||
| miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops. | Q36596742 | ||
| TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets. | Q36659217 | ||
| miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer | Q36745826 | ||
| Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells | Q36937559 | ||
| The TGFBeta pathway as a therapeutic target in cancer. | Q37061588 | ||
| The tumor suppressing effects of QKI-5 in prostate cancer: a novel diagnostic and prognostic protein | Q37610068 | ||
| TGF-β as a therapeutic target in high grade gliomas - promises and challenges. | Q38060439 | ||
| Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival | Q38426352 | ||
| Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-κB pathway | Q39094498 | ||
| The QKI-5 and QKI-6 RNA binding proteins regulate the expression of microRNA 7 in glial cells | Q39210646 | ||
| Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis | Q39351939 | ||
| NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells | Q39606322 | ||
| Genomic profiling identifies discrete deletions associated with translocations in glioblastoma multiforme. | Q40296913 | ||
| Tumor suppressor activity of the TGF-beta pathway in human cancers | Q41157801 | ||
| Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. | Q43246655 | ||
| Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: a population-based analysis | Q44661518 | ||
| Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines | Q48154511 | ||
| High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene | Q48276455 | ||
| SnapShot: glioblastoma multiforme | Q48495755 | ||
| TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma | Q48673261 | ||
| Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. | Q52577959 | ||
| TGF-beta and cancer | Q81484456 | ||
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 2 | |
| P577 | publication date | 2015-02-11 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma | |
| P478 | volume | 14 |
| Q36772047 | Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer |
| Q92481663 | C-reactive protein promotes inflammation through TLR4/NF-κB/TGF-β pathway in HL-1 cells |
| Q59796239 | Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma |
| Q26753819 | Emerging functions of the Quaking RNA-binding proteins and link to human diseases |
| Q65000219 | HOTAIRM1 competed endogenously with miR-148a to regulate DLGAP1 in head and neck tumor cells. |
| Q33276239 | IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance |
| Q41346414 | MiR-148a impairs Ras/ERK signaling in B lymphocytes by targeting SOS proteins |
| Q33648875 | MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations |
| Q92839922 | MiR-148a suppresses invasion and induces apoptosis of breast cancer cells by regulating USP4 and BIM expression |
| Q90285576 | PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion |
| Q96648272 | Role of different Th17 and Treg downstream signalling pathways in the pathogenesis of Staphylococcus aureus infection induced septic arthritis in mice |
| Q26743549 | The Role of Mir-148a in Cancer |
| Q48111289 | The role of the miR-148/-152 family in physiology and disease. |
| Q57453928 | Transforming Growth Factor β1 (TGF-β1)-Stimulated Integrin-Linked Kinase (ILK) Regulates Migration and Epithelial-Mesenchymal Transition (EMT) of Human Lens Epithelial Cells via Nuclear Factor κB (NF-κB) |
| Q37565531 | miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression |
Search more.